ArticleCase reports in surgery2026
Unexpected Link Between Myasthenia Gravis and Lung Adenocarcinoma: A Case Report.
Article in Case reports in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: While myasthenia gravis (MG) is commonly associated with thymic abnormalities and other autoimmune diseases, its association with malignancies, particularly lung adenocarcinoma, is exceptionally rare. Case Presentation: A 65-year-old male presented with bilateral eyelid drooping, double vision, and fatigable limb weakness, alongside a 4-month history of a non-productive cough. Neurological examination revealed bilateral ptosis, sluggish pupillary reactions, and internuclear ophthalmoplegia. Investigations demonstrated elevated anti-acetylcholine receptor (AChR) antibody levels and nerve conduction studies (NCSs) consistent with MG. Imaging revealed a right middle lobe pulmonary nodule, confirmed as adenocarcinoma via fine-needle aspiration. The patient showed symptomatic improvement with pyridostigmine and prednisolone and underwent surgical resection followed by chemotherapy. Discussion: Paraneoplastic neurologic syndromes (PNSs), though rare, can manifest as MG in association with malignancies. While MG is typically linked to thymoma, this case illustrates its coexistence with pulmonary adenocarcinoma, a seldom-reported phenomenon. Cross-reactivity between autoantibodies targeting neuronal and muscle AChRs may underlie the pathophysiology, emphasizing the need to evaluate underlying malignancies in atypical MG presentations. Conclusion: Seropositive MG can present as a paraneoplastic syndrome in association with adenocarcinoma of the lung, highlighting the importance of investigating underlying malignancies in atypical or newly diagnosed autoimmune conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.